Radiotherapy News and Research

RSS
Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Radiotherapy can prolong survival in prostate cancer

Radiotherapy can prolong survival in prostate cancer

Patients once thought incurable can benefit from high-dose radiation therapy

Patients once thought incurable can benefit from high-dose radiation therapy

Notable improvement in brain cancer survival among younger patients but not much for elderly

Notable improvement in brain cancer survival among younger patients but not much for elderly

New guideline supports hypofractionated radiation therapy for men with prostate cancer

New guideline supports hypofractionated radiation therapy for men with prostate cancer

Cornell dots equipped with antibody fragments offer a new cancer weapon

Cornell dots equipped with antibody fragments offer a new cancer weapon

Researchers develop organoid that functions as real salivary gland

Researchers develop organoid that functions as real salivary gland

New hope for children with aggressive form of cancer

New hope for children with aggressive form of cancer

Lumitron HyperVIEW system set to redefine diagnosis and treatment of cancer

Lumitron HyperVIEW system set to redefine diagnosis and treatment of cancer

UCI researchers receive $3.4 million grant to study new class of cancer killing immunotherapeutics

UCI researchers receive $3.4 million grant to study new class of cancer killing immunotherapeutics

New EU project aims to learn more about hormone-disrupting chemicals

New EU project aims to learn more about hormone-disrupting chemicals

Risk-profiling can help improve preventive measures against HIV

Risk-profiling can help improve preventive measures against HIV

Prostatectomy plus radiotherapy associated with greater survival in prostate cancer patients

Prostatectomy plus radiotherapy associated with greater survival in prostate cancer patients

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

Researchers develop molecule that makes cancer cells sensitive to radiotherapy

Researchers develop molecule that makes cancer cells sensitive to radiotherapy

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes

Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes

MILabs' VECTor6 system wins Commercial Innovation Award at WMIC 2018

MILabs' VECTor6 system wins Commercial Innovation Award at WMIC 2018

Targeting pathway controlling mitochondria may reduce cancer invasiveness

Targeting pathway controlling mitochondria may reduce cancer invasiveness

Five microRNAs predict course, recurrence of HPV-negative head and neck cancer

Five microRNAs predict course, recurrence of HPV-negative head and neck cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.